ATE110278T1 - Verfahren und zubereitung für die behandlung von hiv-infizierten säugetieren. - Google Patents

Verfahren und zubereitung für die behandlung von hiv-infizierten säugetieren.

Info

Publication number
ATE110278T1
ATE110278T1 AT91900012T AT91900012T ATE110278T1 AT E110278 T1 ATE110278 T1 AT E110278T1 AT 91900012 T AT91900012 T AT 91900012T AT 91900012 T AT91900012 T AT 91900012T AT E110278 T1 ATE110278 T1 AT E110278T1
Authority
AT
Austria
Prior art keywords
hiv
treatment
preparation
infected mammals
mammal
Prior art date
Application number
AT91900012T
Other languages
English (en)
Inventor
Erfle Volker
Torben Saermark
Original Assignee
Gsf Forschungszentrum Umwelt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gsf Forschungszentrum Umwelt filed Critical Gsf Forschungszentrum Umwelt
Application granted granted Critical
Publication of ATE110278T1 publication Critical patent/ATE110278T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Insects & Arthropods (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT91900012T 1989-12-07 1990-12-07 Verfahren und zubereitung für die behandlung von hiv-infizierten säugetieren. ATE110278T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3940526 1989-12-07

Publications (1)

Publication Number Publication Date
ATE110278T1 true ATE110278T1 (de) 1994-09-15

Family

ID=6395034

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91900012T ATE110278T1 (de) 1989-12-07 1990-12-07 Verfahren und zubereitung für die behandlung von hiv-infizierten säugetieren.

Country Status (11)

Country Link
EP (1) EP0504191B1 (de)
JP (1) JPH075475B2 (de)
KR (1) KR970005329B1 (de)
AT (1) ATE110278T1 (de)
AU (1) AU646652B2 (de)
BR (1) BR9007904A (de)
DE (2) DE504191T1 (de)
DK (1) DK0504191T3 (de)
ES (1) ES2048137T3 (de)
GR (1) GR930300031T1 (de)
WO (1) WO1991008753A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770688A (en) * 1989-12-07 1998-06-23 Gsf-Forschungszentrum Fur Umwelt Und Gesundheit Gmbh Method and composition for the treatment of mammalian HIV infection
DK82892D0 (da) * 1992-06-24 1992-06-24 Michael Hansen Anvendelse af braadgifte fra bier og hvepse til fremstilling af laegemidler til behandling af infektioner
KR100361933B1 (ko) 1993-09-08 2003-02-14 라 졸라 파마슈티칼 컴파니 화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
JP3908274B2 (ja) * 1995-03-09 2007-04-25 ゲーエスエフ−フォルシュンクスツェントラム・フュア・ウムベルト・ウント・ゲズントハイト・ゲーエムベーハー 遺伝子治療用の抗菌ペプチドをコードする治療用遺伝子を有するベクター
AU9531698A (en) * 1997-10-15 1999-05-03 Alk A/S Composition and method for treating an encephalomyelopathic, demyelinating or autoimmune disease
CA2414076A1 (en) 2000-06-08 2001-12-13 La Jolla Pharmaceutical Company Multivalent platform molecules comprising high molecular weight polyethylene oxide
JP2014502607A (ja) * 2011-01-03 2014-02-03 エフ．ホフマン−ラ ロシュ アーゲー 抗ｄｉｇ抗体およびペプチドと結合体化しているジゴキシゲニンの複合体の薬学的組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856936A (en) * 1973-05-07 1974-12-24 Schuyler Dev Corp Composition and method for cortisol control

Also Published As

Publication number Publication date
EP0504191A1 (de) 1992-09-23
ES2048137T3 (es) 1994-10-16
DE69011870D1 (de) 1994-09-29
ES2048137T1 (es) 1994-03-16
DK0504191T3 (da) 1995-03-27
AU6880891A (en) 1991-07-18
BR9007904A (pt) 1992-09-29
JPH075475B2 (ja) 1995-01-25
KR970005329B1 (ko) 1997-04-15
JPH05504761A (ja) 1993-07-22
EP0504191B1 (de) 1994-08-24
AU646652B2 (en) 1994-03-03
WO1991008753A1 (en) 1991-06-27
GR930300031T1 (en) 1993-06-07
DE69011870T2 (de) 1994-12-15
DE504191T1 (de) 1993-04-08

Similar Documents

Publication Publication Date Title
DE3889964D1 (de) Verfahren und Zusammensetzung zur Behandlung und Vorbeugung von Virus-Infektionen.
DE69003652D1 (de) Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzuendlicher und viraler hauterkrankungen.
FR2293219A1 (fr) Procede d'inactivation du virus de l'herpes banal par des agents tensio-actifs et non ioniques
MX163955B (es) Composicion farmaceutica de dihidrocodeina e ibuprofen
DE3750934D1 (de) Behandlung von nicht-Akne-entzündlichen und -infektiösen Hautkrankheiten.
BE873695A (fr) Procede et preparation pour l'inactivation de virus et applications de ceux-ci pour des compositions pharmaceutiques et le traitement de matieres alimentaires
MA21739A1 (fr) Procede de preparation d'une composition pharmaceutique et l'utilisation de n-acycysteines dans le traitement des maladies associees aux infections par hiv .
ATE55695T1 (de) Verwendung von defibrotid zur herstellung pharmazeutischer zusammensetzungen zur behandlung peripherer arteriopathien.
DE69011870D1 (de) Verfahren und zubereitung für die behandlung von hiv-infizierten säugetieren.
SE7803615L (sv) Preparat for behandling av herpes zoster och andra herpesinfektioner jemte forfarande for dess framstellning
MD960168A (ro) Metodă şi compuşi pentru tratamentul infecţiilor virale
DE69004451D1 (de) Prophylaxe und Behandlung von Herpesvirus-Infektionen.
DE3780814D1 (de) Verwendung von nukleosiden zur herstellung eines medikamentes zur behandlung von krankheiten, die durch einen retrovirus oder den hepatitis-b-virus verursacht werden.
ATE143804T1 (de) Zusammensetzung zur behandlung von mastitis und metritis
PT84697A (fr) Procede pour la preparation de compositions pour le traitement de la calvitie et des alopecies contenant phenytoine et diazoxyde
GR3001091T3 (en) Method and composition for prophylaxis and treatment of viral infections
ES2014042A6 (es) Un procedimiento para la preparacion de una composicion de 1-(2'-desoxi -2' fluor -b- d- arabinofuranosil) -5-etiluracilo.
SE8800990D0 (sv) Skin-regenerating cosmetic compositon and process for preparing same
FR2469711A1 (fr) Immunopotentialisateur contenant de la ricine et composition therapeutique le contenant
FI883723A7 (fi) Ihmisen monoklonaaliset vasta-aineet ja niitä vaikuttavana aineosana s isältävät terapeuttiset aineet infektiotauteja vastaan
FR2303558A1 (fr) Preparation therapeutique pour traiter l'infection sous forme de pneumonie hemorragique du vison et de mastite bovine causees par la pseudomonas aeruginosa
FR2612774B1 (fr) Compositions cosmetiques et pharmaceutiques, utilisees pour traiter le processus de l'alopecie androgenogenetique, contenant de l'acide azelaique
BR9307176A (pt) Métodos para identificação de um paciente contaminado com hiv para determinar a eficácia do tratamento de um paciente humano infectado com hiv e processo para identificar os indivíduos contaminados com hiv
EP0491873A4 (en) Therapeutic compositions; methods for treatment of hiv infections
RO81340B1 (ro) Metoda de tratament a unor boli infectioase, de origine virala

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee